| DIRECT COMPETITOR COMPARISON | |
| RGEN | BIO | HGSI | LIFE | Industry | | Market Cap: | 143.02M | 2.71B | 4.47B | 8.91B | 100.26M | | Employees: | 69 | 6,600 | 880 | 9,700 | 68 | | Qtrly Rev Growth (yoy): | 6.50% | 4.30% | 61.30% | 121.40% | 19.70% | | Revenue (ttm): | 21.09M | 1.74B | 235.70M | 2.95B | 14.01M | | Gross Margin (ttm): | 76.58% | 56.30% | 10.36% | 64.07% | 65.67% | | EBITDA (ttm): | -4.07M | 322.53M | -8.22M | 818.22M | -12.30M | | Oper Margins (ttm): | -25.11% | 13.00% | -12.73% | 15.72% | -149.46% | | Net Income (ttm): | -4.76M | 98.54M | -22.51M | 7.87M | N/A | | EPS (ttm): | -0.155 | 3.567 | -0.160 | 0.049 | -0.33 | | P/E (ttm): | N/A | 27.60 | N/A | 1019.39 | 16.37 | | PEG (5 yr expected): | N/A | 1.64 | 186.4 | 1.48 | 1.31 | | P/S (ttm): | 6.78 | 1.56 | 18.98 | 3.02 | 9.35 |
|
| BIO = Bio-Rad Laboratories, Inc. | | HGSI = Human Genome Sciences Inc. | | LIFE = Life Technologies Corporation | | Industry = Biotechnology | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.50 | 0.00% | 57.19B | 12.32 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.92 | 0.00% | 13.57B | 15.70 | | Genzyme Corp. | GENZ | 51.07 | 0.00% | 13.55B | 29.12 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.56 | 0.00% | 41.90B | 18.00 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.95 | 0.00% | 8.91B | 1019.39 | | Teva Pharmaceutical Industries Limited | TEVA | 52.88 | 0.00% | 46.59B | 48.38 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 36.96 | 0.00% | 3.92B | 19.05 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.95 | 0.00% | 2.97B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.01 | 0.00% | 5.50B | 110.49 | | Pfizer Inc. | PFE | 18.25 | 0.00% | 147.27B | 15.16 | | Johnson & Johnson | JNJ | 62.89 | 0.00% | 173.52B | 13.73 | | GlaxoSmithKline plc | GSK | 42.26 | 0.00% | 107.13B | 13.42 | | Sanofi-Aventis | SNY | 38.43 | 0.00% | 100.35B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.38 | 0.00% | 125.78B | 16.58 | | RHHBY.PK | 41.46 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.29 | 0.00% | 65.67B | 9.09 | | Abbott Laboratories | ABT | 54.08 | 0.00% | 83.65B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.38 | 0.00% | 50.28B | 13.13 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | HGSI | | [$$] This Isn't 2003
Fri, Nov 27 -
at RealMoney by TheStreet.com | | • | HGSI | | Human Genome Sciences seeks approval for Zalbin
Wed, Nov 25 -
AP | | • | HGSI | | Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN
Wed, Nov 25 -
Business Wire | | • | LIFE | | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc.
Wed, Nov 25 -
GlobeNewswire | | • | HGSI | | Best Performing U.S. Stocks Year to Date
Tue, Nov 24 -
at Seeking Alpha | | • | HGSI | | Signals Favor a Santa Claus Rally
Tue, Nov 24 -
at Minyanville.com | | • | HGSI | | Wall Street's Buy List
Tue, Nov 24 -
at Motley Fool | | • | BIO | | E-Bay veteran joins Elevation Partners as managing director
Tue, Nov 24 -
at bizjournals.com | | • | LIFE | | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Fri, Nov 20 -
Wall Street Transcript | | • | LIFE | | Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc.
Thu, Nov 19 -
GlobeNewswire | | • | BIO | | Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education
Wed, Nov 18 -
PR Newswire | | • | BIO | | Trading Outlook for Vermillion Inc. Issued by StockPreacher.com
Mon, Nov 16 -
GlobeNewswire | | • | BIO | | Zacks #1 Rank Additions for Monday
Mon, Nov 16 -
Zacks.com | | • | LIFE | | LIFE TECHNOLOGIES CORP Files SEC form 8-K, Unregistered Sale of Equity Securities
Fri, Nov 13 -
EDGAR Online | | • | LIFE | | Desktop Bug Detector
Thu, Nov 12 -
at Forbes.com | | • | BIO | | BIO RAD LABORATORIES INC Financials
Tue, Nov 10 -
EDGAR Online Financials | | • | BIO | | Zacks #1 Rank Additions for Tuesday
Tue, Nov 10 -
Zacks.com | | • | BIO | | Coverage initiated on Bio-Rad Labs by Jefferies & Co
Fri, Nov 6 -
Briefing.com | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 0.00%
Competitors
